Results 21 to 30 of about 528,622 (127)

Use of CytoSorb® hemoadsorption column during prolonged cardiopulmonary bypass in complex cardiac surgery patient [PDF]

Journal of Cardiothoracic Surgery, 2022
Background Complex cardiac surgery and prolonged cardiopulmonary bypass are associated with significant activation of the systemic inflammatory response system.
Marianne Alarie, Maggie Savelberg, Danika Vautour, Igo B. Ribeiro   +3 more
doaj   +2 more sources

The use of CytoSorb hemoadsorption in critically ill patients: a narrative review [PDF]

Frontiers in Medicine
Inflammation, a complex biological response against injury or infection, is an important pathological basis for various critical diseases. A “normal” immune response exemplifies a balanced dialogue between immunological cells and a medley of pro- and ...
Kaixin Lei, Ao Chen, Xinqi An, Jun Guo, Baihai Su, Baihai Su, Baihai Su, Yupei Li   +7 more
doaj   +2 more sources

Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19

Pharmacology Research & Perspectives, 2021
Both antiviral treatment with remdesivir and hemoadsorption using a CytoSorb® adsorption device are applied in the treatment of severe COVID‐19. The CytoSorb® adsorber consists of porous polymer beads that adsorb a broad range of molecules, including ...
Paul Biever, Dawid L. Staudacher, Michaela J. Sommer, Hannah Triebel, Merja A. Neukamm, Christoph Bode, Alexander Supady, Achim Lother   +7 more
doaj   +2 more sources

Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial

Critical Care, 2019
Background Cardiopulmonary bypass (CPB) is often associated with degrees of complex inflammatory response mediated by various cytokines. This response can, in severe cases, lead to systemic hypotension and organ dysfunction.
Elettra C Poli, Lorenzo Alberio, Anna Bauer-Doerries, Carlo Marcucci, Aurélien Roumy, Matthias Kirsch, Eleonora De Stefano, Lucas Liaudet, Antoine G Schneider   +8 more
doaj   +2 more sources

The use of CytoSorb® in a prasugrel‐loaded patient undergoing emergent coronary artery bypass graft surgery [PDF]

Clinical Case Reports, 2023
Patients with acute coronary syndrome (ACS), failed percutaneous coronary intervention (PCI) and with an indication for emergent coronary artery bypass graft surgery (CABG) are at an increased risk of perioperative bleeding. Integration of the CytoSorb® (
Erich Moresco, Hannes Dejaco, Volker Humbert, Matthias Thoma   +3 more
doaj   +2 more sources

Effective Apixaban removal using hemoadsorption during emergent open-heart surgery: a case report and narrative literature review

Journal of Cardiothoracic Surgery
Background The management of hemostasis in patients medicated with apixaban (Eliquis) undergoing emergency cardiac surgery is exceedingly difficult. The body’s natural elimination pathways for apixaban prove ineffective in emergency situations, and the ...
Vitor Mendes, Jaid Mamode, Jalal Jolou, Mourad Malki, Christoph Ellenberger, Mustafa Cikirikcioglu, Christoph Huber   +6 more
doaj   +2 more sources

Cytokine hemoadsorption with CytoSorb® in patients with sepsis: a systematic review and meta-analysis. [PDF]

Crit Care Sci, 2023
Objective: To analyze the effect of CytoSorb® on mortality, interleukin levels, vasopressor use and adverse events in patients with sepsis. Methods: We searched MEDLINE®, Embase and the Cochrane Library for randomized controlled trials and cohort studies
Saldaña-Gastulo JJC, Llamas-Barbarán MDR, Coronel-Chucos LG, Hurtado-Roca Y.   +3 more
europepmc   +2 more sources

Hemadsorption with Adult CytoSorb® in a Low Weight Pediatric Case

Case Reports in Critical Care, 2017
Cytokine adsorber (CytoSorb) has been used successfully as adjunctive treatment for adult patients with elevated cytokine levels in the setting with severe sepsis and septic shock and to reduce blood myoglobin, unconjugated bilirubin, and conjugated ...
Catalin Gabriel Cirstoveanu, Ileana Barascu, Samantha Mc Kenzie Stancu   +2 more
doaj   +2 more sources

Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption

Case Reports in Cardiology, 2019
A 67-year-old woman with a history of end-stage renal disease on hemodialysis received a therapeutic dose (150 mg daily) of flecainide for three weeks.
Nicolas De Schryver, Philippe Hantson, Vincent Haufroid, Mélanie Dechamps   +3 more
doaj   +2 more sources

Revolutionizing Severe Malaria Management: The Role of CytoSorb® Hemoadsorption in Treating Malaria-Induced Liver Dysfunction. [PDF]

Cureus
: Malaria, caused by Plasmodium falciparum (PF), can lead to severe liver dysfunction and hyperbilirubinemia, worsening the prognosis. A 53-year-old male patient with malaria-related liver dysfunction and severe hyperbilirubinemia was treated with ...
De Rosa RC, Romanelli A, Giurazza R, Falso F, Viola G.   +4 more
europepmc   +2 more sources